Effect of ursodeoxycholic acid (UDCA) on dyspepsia in patients with gallstones or other biliary tract anomalies

P. Bianchi, D. Conte, L. Sironi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

A doubel-blind controlled trial was carried in two groups of dyspeptic patients affected by biliary tract conditions with or without gallstones to study the effect of ursodeoxycholic acid (UDCA) on dyspeptic and painful disturbances. The UDCA was compared to placebo according to a 'between subjects' design; the treatment schedule was one capsule or UDCA 150 mg or placebo twice a day during 14 days. The results show a highly significant effect of UDCA compared to placebo with a remarkable improvement of the symptoms after a very short duration of treatment. UDCA appears very useful in the treatment of biliary dyspepsia although its exact mode of action requires further investigations.

Original languageEnglish
Pages (from-to)230-233
Number of pages4
JournalCurrent Therapeutic Research
Volume26
Issue number2
Publication statusPublished - 1979

Fingerprint

Ursodeoxycholic Acid
Dyspepsia
Biliary Tract
Gallstones
Placebos
Capsules
Appointments and Schedules
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of ursodeoxycholic acid (UDCA) on dyspepsia in patients with gallstones or other biliary tract anomalies. / Bianchi, P.; Conte, D.; Sironi, L.

In: Current Therapeutic Research, Vol. 26, No. 2, 1979, p. 230-233.

Research output: Contribution to journalArticle

@article{5cdef4267431433b9594fc722079dbf4,
title = "Effect of ursodeoxycholic acid (UDCA) on dyspepsia in patients with gallstones or other biliary tract anomalies",
abstract = "A doubel-blind controlled trial was carried in two groups of dyspeptic patients affected by biliary tract conditions with or without gallstones to study the effect of ursodeoxycholic acid (UDCA) on dyspeptic and painful disturbances. The UDCA was compared to placebo according to a 'between subjects' design; the treatment schedule was one capsule or UDCA 150 mg or placebo twice a day during 14 days. The results show a highly significant effect of UDCA compared to placebo with a remarkable improvement of the symptoms after a very short duration of treatment. UDCA appears very useful in the treatment of biliary dyspepsia although its exact mode of action requires further investigations.",
author = "P. Bianchi and D. Conte and L. Sironi",
year = "1979",
language = "English",
volume = "26",
pages = "230--233",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "2",

}

TY - JOUR

T1 - Effect of ursodeoxycholic acid (UDCA) on dyspepsia in patients with gallstones or other biliary tract anomalies

AU - Bianchi, P.

AU - Conte, D.

AU - Sironi, L.

PY - 1979

Y1 - 1979

N2 - A doubel-blind controlled trial was carried in two groups of dyspeptic patients affected by biliary tract conditions with or without gallstones to study the effect of ursodeoxycholic acid (UDCA) on dyspeptic and painful disturbances. The UDCA was compared to placebo according to a 'between subjects' design; the treatment schedule was one capsule or UDCA 150 mg or placebo twice a day during 14 days. The results show a highly significant effect of UDCA compared to placebo with a remarkable improvement of the symptoms after a very short duration of treatment. UDCA appears very useful in the treatment of biliary dyspepsia although its exact mode of action requires further investigations.

AB - A doubel-blind controlled trial was carried in two groups of dyspeptic patients affected by biliary tract conditions with or without gallstones to study the effect of ursodeoxycholic acid (UDCA) on dyspeptic and painful disturbances. The UDCA was compared to placebo according to a 'between subjects' design; the treatment schedule was one capsule or UDCA 150 mg or placebo twice a day during 14 days. The results show a highly significant effect of UDCA compared to placebo with a remarkable improvement of the symptoms after a very short duration of treatment. UDCA appears very useful in the treatment of biliary dyspepsia although its exact mode of action requires further investigations.

UR - http://www.scopus.com/inward/record.url?scp=0018646496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018646496&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0018646496

VL - 26

SP - 230

EP - 233

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 2

ER -